• News

"Bioimpedance Spectroscopy Helps Prevent Breast Cancer-related Lymphedema Progression" - Marilynn Larkin

  • MD Alert
  • New York, NY
  • (May 08, 2019)

For triggering compression therapy to prevent progression of breast cancer-related lymphedema, bioimpedance spectroscopy appears to be more effective than standard tape measure assessment of arm circumference, according to interim results of the PREVENT trial reported at the American Society of Breast Surgeons annual meeting. Fewer women in the trial went on to develop clinical lymphedema when referred for therapy using BIS than traditional TM, suggesting that BIS is a highly effective tool for pinpointing patients at risk. Paul Schmidt, MD, PhD, associate professor of surgery at the Icahn School of Medicine at Mount Sinai who was not involved in the study said, "The L-DEX device used in the study has been available for several years but I think the data are still evolving. This trial has been going on for a while and this is an interim analysis."

— Paul H. Schmidt, MD, PhD, Associate Professor, Surgery, Icahn School of Medicine at Mount Sinai, Director, Cancer Risk Program, Dubin Breast Center, Mount Sinai Health System

Learn more